A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

This is a survey of factors which affect a pathologically defined early or delayed diagnosis of IgA nephropathy in Guangdong General Hospital, Guangzhou, China. An early or delayed diagnosis of IgA nephropathy is pathologically defined using the recently published Oxford classification of IgA nephropathy. The factors to be surveyed include health examination including urine test, socioeconomic status of patients including education,etc.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

IgA Nephropathy Autoimmune Diseases Disease Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glomerulonephritis Glomerulonephritis, IGA Immune System Diseases Kidney Diseases Male Urogenital Diseases Nephritis Pathologic Processes Pathological Conditions, Signs and Symptoms Urogenital Diseases Urologic Diseases

Age range

14 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Nephrology Department,Guangdong General Hospital

Guangzhou, Guangdong, 510080, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

biopsy-proven IgA Nephropathy patients in Guangdong General Hospital, Guangzhou,China

Treatment and study plan

Primary outcomes

Factors potentially affecting an early or delayed diagnosis of IgA Nephropathy

Time frame: Before the biopsy

Secondary outcomes

Glomerular filtration rate(GFR) decline rate or reaching end-stage renal disease (ESRD) or doubling of serum creatinine

Time frame: after the biopsy

Sponsors and collaborators

Lead sponsor

Guangdong Provincial People's Hospital

Other

Registry information

Official study title

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy: an Observational Study

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2012
First posted: Feb 24, 2012
Registry last updated: Aug 19, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed